EcoDrugPlus

Atpase H+/k+ Transporting Subunit Beta

Ensembl ID : ENSUAMG00000006542
Gene Symbol: ATP4B
2 Cross references
184 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 1

Ensembl ID : ENSUAMG00000004877
Gene Symbol: ATP1A1
2 Cross references
322 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 2

Ensembl ID : ENSUAMG00000012224
Gene Symbol: ATP1A2
2 Cross references
205 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 3

Ensembl ID : ENSUAMG00000021235
Gene Symbol: ATP1A3
1 Cross references
134 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 4

Ensembl ID : ENSUAMG00000019930
Gene Symbol: ATP1A4
2 Cross references
564 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 1

Ensembl ID : ENSUAMG00000023827
Gene Symbol: ATP1B1
2 Cross references
295 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 2

Ensembl ID : ENSUAMG00000001206
Gene Symbol: ATP1B2
2 Cross references
274 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 3

Ensembl ID : ENSUAMG00000018885
Gene Symbol: ATP1B3
2 Cross references
299 Possible Orthologues:

Axl Receptor Tyrosine Kinase

Ensembl ID : ENSUAMG00000010248
Gene Symbol: AXL
2 Cross references
197 Possible Orthologues:

B-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSUAMG00000019248
Gene Symbol: BRAF
2 Cross references
220 Possible Orthologues:

Bcl2 Apoptosis Regulator

Ensembl ID : ENSUAMG00000009626
Gene Symbol: BCL2
2 Cross references
227 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSUAMG00000023496
Gene Symbol: BCL2L1
2 Cross references
286 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).